A nutraceutical biologic for anorexia? Pronutria Biosciences closes $39M Series C
The startup's building a portfolio of 1 billion protein sequences and tools to determine which disease they could help treat. Pronutria has raised $65 million to date for a nutraceutical approach to disease management - particularly those that cause muscle-wasting.